Management of Prenatally Diagnosed Isolated Right Aortic Arch (ARCADE)

March 9, 2020 updated by: University Hospital, Montpellier

Management of Prenatally Diagnosed Isolated Right Aortic Arch: the ARCADE Study

The existence of a right aortic arch integrates nosologically into the group of aortic vascular arch anomalies. In the majority of cases, a right aortic arch is associated with cono-truncal congenital heart diseases (CHD), such as tetralogy of Fallot, pulmonary atresia with ventricular septal defect, and truncus arteriosus. Sometimes, a right aortic arch can be isolated, with an incidence of 0.05% to 0.1 %. Therefore, an assessment of the anatomy is necessary because an isolated right aortic arch can be associated with an encircling aortic arch anomaly and may subsequently have a functional repercussion, creating a digestive obstacle (oesophageal compression) and/or a respiratory obstacle (tracheal compression).

Furthermore, indications for surgery in this type of abnormalities are not well-established.

The diagnosis of a vascular artery anomaly is currently mostly made prenatally, with increasing diagnostic accuracy. Indeed, the application of the "3VT view" (e.g. three vessels and tracheae view) in routine prenatal sonographic screening for CHD has contributed to a better identification of such anomalies.

Prenatal diagnosis of an isolated right aortic arch involves the identification of the following aspects: the existence of a left ductus arteriosus may relate to an increased risk of an encircling aortic arch anomaly at birth; the analysis of the different vessels of the aortic arch, which can be difficult because of the fetal circulation and the maternal-fetal conditions of the examination; and the absence of a thymus, which suggests the existence of a genetic anomaly, such as DiGeorge syndrome.

After birth, the evaluation of the functional repercussion of the anomaly remains complex. The incidence of secondary symptoms to encircling abnormalities is estimated at 25%, but varies according to the anomaly: it is very frequent in case of a double aortic arch, variable in case of a right aortic arch with left ductus arteriosus (from 9% to 47% in the literature), absent in case of right aortic arch with right ductus arteriosus. Postnatal echocardiography can only assess the existence of a right aortic arch and check ductus arteriosus closure. The complete anatomical diagnosis of a vascular artery anomaly can only be made by slice cardiac imaging (CT scan or MRI), but in practice these examinations are not routinely performed in the absence of neonatal symptoms.

The aim of this study is to evaluate the accuracy of prenatally diagnosed isolated right aortic arch in terms of anatomy and functional prognosis.

The secondary aims are :

  • to specify the association of an isolated right aortic arch with a genetic anomaly,
  • to define the role of CT scan in children prenatally diagnosed with right aortic arch, in terms of diagnosis, prognosis and follow-up,
  • to evaluate the incidence of respiratory and digestive complications in the first year of life,
  • to evaluate the indications for surgical management during the first year of life.

Study Overview

Status

Completed

Detailed Description

Retrospective (from 2010 to 2019), multicentre, observational study carried out in the French national M3C network (complex CHD expert centers).

Patients with a prenatal diagnosis of isolated right aortic arch will be included. Patients with a right aortic arch associated with any CHD will be excluded, as well as patients whose parents refuse the use of medical data of their child.

The following data will be collected:

Clinical data:

  • Functional signs of tracheal or esophageal compression in the first year of life.
  • Association with a genetic syndrome.

Echocardiographic data:

  • Prenatal: anatomical description of the aorta and supra-aortic trunks. Position of the ductus arteriosus, presence of a thymus.
  • Postnatal: confirmation of the right aortic arch, absence of conotruncal CHD, closure of the ductus arteriosus.

If performing a chest CT scan in the first year of life:

  • Reason: systematic or on symptoms,
  • Age of realization,
  • Anatomical analysis of the aortic arches,
  • Concordance with antenatal diagnosis,
  • Evaluation of the degree of tracheal compression,
  • Screening for a vascular complication.

If performing an ante- or post-natal genetic sampling:

  • Type of sampling if antenatal: amniocentesis or trophoblast biopsy,
  • Type of analysis: karyotype, FISH, CGH array,
  • Molecular diagnosis.

If performing a surgery during the first year of life:

  • Indication: prophylactic or symptomatic,
  • Type of intervention,
  • Age at the intervention

Study Type

Observational

Enrollment (Actual)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • UH Montpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Children with antenatal diagnosis of isolated right aortic arch

Description

Inclusion criteria:

• Prenatal diagnosis of an isolated right aortic arch

Exclusion criteria:

  • Association with any congenital heart disease according to the ACC-CHD (Orphanet) classification
  • Postnatal diagnosis of an isolated right aortic arch
  • Refusal of parents to use medical data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between the antenatal description of isolated right aortic arch and the postnatal description and functional prognosis
Time Frame: 1 day
Correlation between the antenatal description of isolated right aortic arch and the postnatal description and functional prognosis
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of genetic anomaly with an isolated right aortic arch
Time Frame: 1 day

Incidence of genetic anomaly with an isolated right aortic arch by specifying :

  • diagnosed retained
  • type of sampling : amniocentesis, trophoblast biopsy, blood test
  • type of analysis: karyotype, FISH, CGH array
1 day
Rate of realization of chest CT angiography before the first year of life with an isolated right aortic arch
Time Frame: 1 day

If performing a chest CT scan the first year of life:

  • Reason: systematic or on symptoms
  • Age of realization
  • Anatomical analysis of the aortic arches
  • Concordance with antenatal diagnosis
  • Evaluation of the degree of tracheal compression
1 day
Rate of surgical repair during the first year of life after prenatal diagnosis of an isolated right aortic arch.
Time Frame: 1 day

If performing a surgery the first year of life:

  • Indication: prophylactic or symptomatic
  • Type of intervention
  • Age at the intervention
1 day
Rate of respiratory and digestive complications in the first year of life.
Time Frame: 1 day
Functional signs of tracheal or esophageal compression in the first year of life.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2019

Primary Completion (Actual)

December 1, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

April 25, 2019

First Submitted That Met QC Criteria

July 22, 2019

First Posted (Actual)

July 23, 2019

Study Record Updates

Last Update Posted (Actual)

March 10, 2020

Last Update Submitted That Met QC Criteria

March 9, 2020

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • RECHMPL19_0146

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

NC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Isolated Right Aortic Arch

3
Subscribe